Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
DE Stocks

1EZ0.F Europlasma down 23% to €0.02 on XETRA 12 Mar 2026: risks remain

March 13, 2026
5 min read
Share with:

1EZ0.F stock plunged -23.28% to EUR 0.0201 on XETRA as the market closed on 12 Mar 2026, marking it among today’s top losers. We tracked a thin session with volume 1,944 and a low of €0.0201, versus a previous close of €0.0262. Traders cited poor fundamentals and low liquidity; the shares trade far below their 50-day average of €0.09 and 200-day average of €4.68. This report breaks down price action, fundamentals, technicals, Meyka AI grading, and a model-based forecast to guide market participants.

Price action and session summary

Europlasma S.A. (1EZ0.F) fell -23.28% to €0.0201 on XETRA at market close on 12 Mar 2026. The stock opened at €0.0228, hit a high of €0.0228 and a low of €0.0201. Trading volume was 1,944, below the average volume of 8,861, but the relative volume was elevated at 2.03x, showing short, high-impact trades.

Sponsored

The intraday move cut market cap to approximately €42,184,456.00 and continued a steep YTD decline of -88.95%. With a one-year change of -99.96%, price action reflects both low liquidity and long-term structural weakness.

1EZ0.F stock fundamentals and valuation

Fundamentals are challenged: reported EPS is -88.61, and the company shows negative profitability metrics with net margin -36.02% and operating margin -62.58%. Book value per share is negative at -0.01, and shareholders’ equity per share is -0.01, flagging balance-sheet stress. Revenue per share TTM is 0.04, giving a price-to-sales ratio near 0.00 at current levels.

Europlasma operates in Waste Management and Industrials with 1,870 employees and 1,842,116,000 shares outstanding. Corporate details and disclosures are available on the company site Europlasma website.

Technicals, liquidity and trading risks for 1EZ0.F stock

Technicals show an oversold setup: RSI 31.66, CCI -146.69, and MFI 16.48. MACD is flat negative and ADX 15.60 indicates no established trend. Bollinger Bands sit 0.02–0.04, highlighting compressed price action and high volatility relative to price.

Low average volume (8,861) and current volume (1,944) increase execution risk. On XETRA, thin trading can produce outsized moves and wide spreads, which is a key risk for short-term traders and limit-order strategies.

Meyka AI rates 1EZ0.F with a score out of 100

Meyka AI rates 1EZ0.F with a score out of 100: 66.32 / Grade B / Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The model balances a weak balance sheet and negative margins against sector comparators and potential upside scenarios.

This grade is an informational metric, not investment advice. Grades are model-based and not guarantees; investors should perform their own research.

Catalysts, sector context and risks

Catalysts that could change the outlook include new contracts for hazardous-waste treatment, improved cash-flow reports, or regulatory support for decarbonization technologies. The Industrials sector has shown 6M performance of +7.57%, but Europlasma’s specific metrics lag sector averages such as ROE ~16.46% for peers.

Primary risks are persistent negative EPS, thin liquidity, extended receivables days (143 days), and a stretched cash position (cash per share €0.00). Debt-to-market-cap sits at 212.99%, underscoring leverage and market-cap sensitivity to price moves.

Meyka AI’s forecast and price targets

Meyka AI’s forecast model projects a 12-month base-case price of €0.01, and a bull-case target of €0.05. Versus the current price of EUR 0.0201, the base-case implies a downside of -50.25%, while the bull-case implies upside of +148.81%. Forecasts are model-based projections and not guarantees.

We present a conservative near-term price target of €0.01–€0.03 for risk-managed portfolios and a high-risk speculative target €0.05 for scenario planning. For real-time quotes and trade execution reference Meyka: 1EZ0.F and market data providers such as FinancialModelingPrep profile.

Final Thoughts

Europlasma S.A. (1EZ0.F) closed as one of XETRA’s top losers on 12 Mar 2026, down -23.28% to €0.0201 on thin volume. Fundamentals remain weak with EPS -88.61, negative book value, and stressed liquidity. Technicals show oversold signals but offer no reliable trend confirmation. Meyka AI rates the stock 66.32 / Grade B / HOLD and models a conservative 12-month base-case €0.01 (implied -50.25% from €0.0201) and a bull-case €0.05 (implied +148.81%). These targets frame a high-risk reward profile: downside dominates the base case, while any contract wins or balance-sheet improvements could trigger outsized moves. We recommend risk-aware position sizing, strict stop rules, and monitoring corporate updates and liquidity. Forecasts and grades are model outputs and not guarantees; conduct your own due diligence and consult licensed advisors before trading.

FAQs

What drove the 1EZ0.F stock drop on 12 Mar 2026?

The drop reflected weak fundamentals, negative EPS (-88.61), low liquidity, and short-term selling pressure. Volume was 1,944, below average, amplifying price moves. Sector underperformance and balance-sheet concerns also contributed to selling.

What is Meyka AI’s price forecast for 1EZ0.F stock?

Meyka AI’s forecast model projects a 12-month base-case price €0.01 (implied -50.25% vs €0.0201) and a bull-case €0.05 (implied +148.81%). Forecasts are model-based projections and not guarantees.

Is 1EZ0.F stock a buy after this decline?

Given negative margins, EPS -88.61, and low liquidity, we view the stock as high risk. Meyka AI’s grade is B / HOLD. Investors seeking exposure should use small sizes and strict risk controls.

Where can I find company filings for Europlasma (1EZ0.F)?

Europlasma corporate disclosures and news are on the company site Europlasma website. For market data and profiles use recognized data providers and the XETRA feed.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
12% average open rate and growing
Trusted by 4,200+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)